Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$115,082,919
+$29,678,596 QoQ
Shares Held
95,948
+3.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#359
of 4,621 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $978,265,315 across 7 Drug Manufacturers - General names. LLY ranks #6 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,279,269 | $242,574,987 | |
| 2 | PFE |
Pfizer Inc
|
7,612,597 | $183,311,335 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
3,053,480 | $175,941,517 | |
| 4 | BIIB |
Biogen Inc.
|
570,974 | $123,364,642 | |
| 5 | ABBV |
AbbVie Inc.
|
482,591 | $121,439,199 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
95,948 | $115,082,919 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $16,550,716 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,082,919 | 95,948 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $85,404,323 | 92,854 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $93,191,959 | 86,716 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $28,353,843 | 37,161 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $56,201,774 | 72,097 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $61,999,411 | 75,068 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $46,559,320 | 60,310 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $49,146,635 | 55,474 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $38,664,252 | 42,705 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $51,250,448 | 65,878 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $38,835,879 | 66,623 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $56,990,567 | 106,102 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $54,303,663 | 115,791 | Shares | Sole | 2023-07-19 | |
| 2022-03-31 | $27,212,595 | 95,026 | Shares | Sole | 2022-04-21 | |
| 2020-09-30 | $5,656,436 | 38,214 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $6,762,410 | 41,189 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $3,734,064 | 26,918 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||